Home › Eosinophilic Esophagitis › NCT07234825

Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis

Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis Induction of Remission

Who can join

Ages 1 to 21 · All sexes

Inclusion Criteria:

* Pediatric patients 1 year to 21 of age presenting with chronic symptoms of dysphagia, odynophagia, vomiting or heartburn, chronic abdominal pain, weight loss, picky eating, to outpatient gastroenterology clinic and are planning to undergo EGD for evaluation.

Exclusion Criteria:

* Non-English-Speaking Subjects, adults unable to consent, wards of the state, pregnant women, and prisoners will be excluded from the study.
* Patients with autoimmune conditions such as inflammatory bowel disease. Patients with prior esophageal or intestinal surgeries.
* Patients with history of eating disorders or ARFID.
* Patients with fistulizing or fibrotic disease on baseline EGD.
* Patients who have received proton pump inhibitory therapy in the past month.

About the study

This study aims to introduce a new dietary therapy for Eosinophilic Esophagitis (EoE) patients by using partial enteral nutrition (PEN) to enhance remission rates and explore how this approach affects immune function, gut microbiota, and environmental toxin exposures.

What is being tested

• Partial enteral nutrition (PEN) with dairy elimination (other)
• Dairy elimination alone (other)

Sponsor: Kate Farms Inc · Participants: 36 · Started: Mar 18, 2026

Contact the study team

• Danny Gagucas · Phone: 206-987-1062

Official record on ClinicalTrials.gov — NCT07234825

Locations in the U.S.

Conditions

• Eosinophilic Esophagitis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.